Reauthorizing and Extending Grants for Recovery From Opioid Use Programs Act of 2018

Floor Speech

Date: June 13, 2018
Location: Washington, DC

BREAK IN TRANSCRIPT

Mr. GOODLATTE. Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 6029) to amend the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize the comprehensive opioid abuse grant program, and for other purposes.

The Clerk read the title of the bill.

BREAK IN TRANSCRIPT

Mr. GOODLATTE. 6029, currently under consideration.

Mr. Speaker, in July 2016, Congress enacted the Comprehensive Addiction and Recovery Act, otherwise known as CARA. The statistics then were shocking, and, unfortunately, they have not yet subsided. In 2016, more than 64,000 Americans died from drug overdoses, including illicit drugs and prescription opioids. This figure has nearly doubled in the past decade.

Part of CARA created a comprehensive opioid abuse reduction program at the Department of Justice which directs Federal resources for drug abuse programs targeted at the opioid problem within our criminal justice system.

By establishing this competitive grant program, CARA gives States and localities maximum flexibility to attack opioid abuse issues unique to their communities. States are now able to use the grant funds for a variety of important criminal justice programs, including alternatives to incarceration, treatment programs for incarcerated individuals, juvenile opioid abuse, investigation and enforcement of drug trafficking and distribution laws, and significant training for first responders in carrying and administering opioid overdose reversal drugs, like naloxone. States can enlist nonprofit organizations, including faith-based organizations, in the fight against opioid abuse.

In 2016, CARA authorized this new program at $103 million annually over 5 years. However, 3 months ago, Congress tripled that authorization to $330 million, including funds for drug courts, mental health courts, residential drug abuse treatment for State prisoners, and veterans' treatment courts. Therefore, the bill before us results in no net increase in spending authorizations and no additional burden on the American taxpayer, which is a responsible, good government approach to this epidemic.

This bill reauthorizes the CARA program through 2023, so we can make sure there is no lapse in our efforts against drug addiction.

While Members of this body should be proud of our accomplishments, there is still much more work to do. I urge my colleagues to support this bill and thereby reassure all Americans that we are committed to fighting the opioid epidemic.


Source
arrow_upward